Your session is about to expire
← Back to Search
INSPIRE Stewardship Bundle for Skin and Soft Tissue Infections
Study Summary
This trial is testing whether real-time, precision medicine computerized physician order entry (CPOE) smart prompts can help improve antibiotic stewardship practices for skin and soft tissue infections in adults.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The facility uses MEDITECH as its electronic health record system.The study is not being conducted at a location convenient for you.I am admitted to a HCA Healthcare hospital for a skin or soft tissue infection.
- Group 1: Arm 2: INSPIRE Stewardship Bundle
- Group 2: Arm 1: Routine Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial actively recruiting participants?
"Right, the information located on clinicaltrials.gov demonstrates that this particular medical experiment is actively searching for participants. It was first announced on August 2nd 2022 and most recently updated on August 29th 2022. Around 102 people must be recruited from 100 sites in total."
Are there any medical centers in North America conducting this clinical investigation?
"The approved list of clinical trial sites contains 100 hospitals, including Englewood Community Hospital in Englewood, Medical City Fortworth in Fort Worth and Trident Medical Center in Charleston."
What is the maximum capacity for participants in this investigation?
"Affirmative. According to clinicaltrials.gov, this scientific study is presently recruiting participants with initial postings dating back to August 2nd 2022 and last updated on the 29th of the same month. 102 individuals are needed for enrollment across 100 sites worldwide."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger